NORIFISH AS has a total of 12 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2017. It filed its patents most often in Denmark, EPO (European Patent Office) and Canada. Its main competitors in its focus markets biotechnology, basic materials chemistry and pharmaceuticals are ROMVAC COMPANY S A, CHANGSHA QINCAI BIOLOGICAL TECH CO LTD and IPSEN MFG IRELAND LIMITED.
# | Country | Total Patents | |
---|---|---|---|
#1 | Denmark | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 2 | |
#4 | Chile | 2 | |
#5 | Norway | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Basic materials chemistry | |
#3 | Pharmaceuticals | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Preservation of human bodies | |
#3 | Medical preparations | |
#4 | Fodder |
# | Name | Total Patents |
---|---|---|
#1 | Skjervold Per Olav | 9 |
#2 | Evensen Øystein | 7 |
#3 | Morlandstø Jan Ove | 7 |
#4 | Per Olav Skjervold | 3 |
#5 | Øystein Evensen | 3 |
#6 | Jan Ove Morlandstø | 3 |
#7 | Morlandsto Jan Ove | 2 |
#8 | Evensen Oystein | 2 |
Publication | Filing date | Title |
---|---|---|
NO20200511A1 | IgY antibodies for the prevention of sea lice infestation and infection | |
NO20200512A1 | IgY antibodies for the prevention of sea lice infestation and infection | |
EP3405487A1 | Igy antibodies for the prevention of sea lice infestation and infection |